University Health System Texas Diabetic Institute

San Antonio, Texas 78207

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Diabetes Mellitus, Type 2 Clinical Trial
Can Exenatide Prevent the Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
Status: Enrolling, Phase IV
Updated: 3/19/2018
University Health System Texas Diabetic Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials